Author's reply to Comment on "A randomized clinical trial of Saccharomyces cerevisiae versus placebo in the irritable bowel syndrome" by Guillaume Pineton de Chambrun et al. [Digestive and Liver Disease 2015;47:119-24].
CHU Lille, Department of Gastroenterology, Claude Huriez Hospital, Lille, France; Lille University North of France, Lille, France; INSERM U995, Lille, France. Electronic address: pdesreumaux@hotmail.com.
Pierre
P
Desreumaux
D015746:Abdominal Pain / Q000628:therapy*; D005260:Female; D006801:Humans; D043183:Irritable Bowel Syndrome / Q000628:therapy*; D008297:Male; D019936:Probiotics / Q000627:therapeutic use*; D012441:Saccharomyces cerevisiae